Halozyme Names Dr. Alison A. Armour As Senior Vice President of Research and Development

SAN DIEGO, May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of biotechnology and pharmaceuti... Biopharmaceuticals, Oncology, Personnel Halozyme Therapeutics, pegvorhyaluronidase
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news